Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Mutations in the ATP1A3 gene encoding the α3 subunit of Na+/K+-ATPase are associated with different neurological manifestations that may be elicited by febrile episodes. A recently described phenotype, linked to the p.Arg756Cys mutation, is clinically characterized by Relapsing Encephalopathy with Cerebellar Ataxia (RECA). In our case, a diagnosis of RECA has been established, and despite an alternative, reasonable cause had been already identified. We describe the case of a child with two recurrent episodes, 2 years apart, of hypotonia and ataxia. In both episodes, a laboratory-confirmed influenza virus infection suggested the diagnosis of influenza-associated encephalopathy. After the second episode, a search for genetic mutations was performed, and ATP1A3 mutation associated to RECA was found. After both episodes, the child was discharged after partial improvement of neurological conditions. The diagnosis of encephalopathy in children is often challenging. A genetic predisposition to neurological decompensation should be suspected in case of recurrent episodes, even if an alternative diagnosis has been established. Indeed, febrile infections may only represent the trigger of neurological involvement. In these patients, the knowledge of a genetic predisposing factors may help in the prevention of neurological episodes by the prompt use of anti-pyrectics and preventive measures as appropriate vaccination.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715801PMC
http://dx.doi.org/10.3389/fneur.2021.774054DOI Listing

Publication Analysis

Top Keywords

atp1a3 gene
8
recurrent episodes
8
episodes
6
neurological
5
relapsing neurological
4
neurological complications
4
complications child
4
child atp1a3
4
gene mutation
4
mutation influenza
4

Similar Publications

Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients.

Brain

August 2025

Movement Disorders Program, Department of Neurology & F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Epilepsy-dyskinesia syndromes (EDS) are a complex group of neurogenetic disorders characterized by the co-occurrence of epilepsy and movement disorders. Despite their increasing clinical recognition, the molecular and clinical spectrum of EDS remain poorly understood. While numerous genetic etiologies have been implicated, systematic characterization across diverse populations is lacking.

View Article and Find Full Text PDF

Huntington disease (HD) is a neurodegenerative disease caused by a trinucleotide repeat expansion in the HTT gene encoding an elongated polyglutamine tract in the huntingtin (HTT) protein. The use of biomarkers has become a major component in preclinical studies focusing on HTT lowering strategies. Quantification of soluble mutant HTT (mHTT) in cerebrospinal fluid (CSF) has served as a pharmacodynamic readout and as potential disease progression biomarker.

View Article and Find Full Text PDF

Rapid-onset dystonia-parkinsonism: First African case of ATP1A3 mutation.

Parkinsonism Relat Disord

September 2025

Université Hassan II de Casablanca, Faculté de Médecine et de Pharmacie de Casablanca, Rue tarik Ibn Ziad, Casablanca, 20100, MA, Morocco; Département de Neurologie, CHU Ibn Rochd, Morocco; Laboratoire De Recherche Sur les Maladies du Système Nerveux, Neurosensorielles et Handicap, Faculté de

Rapid-onset dystonia-parkinsonism (RDP), also known as DYT12 dystonia, is a rare neurological disorder caused by a mutations in the ATP1A3 gene. It typically presents with a sudden or rapidly progressive onset of dystonia, parkinsonism, and bulbar symptoms, which tend to stabilize shortly after onset and show minimal to no response to levodopa treatment. We report the first documented case of RDP in Africa, involving a Moroccan patient carrying a novel ATP1A3 mutation.

View Article and Find Full Text PDF

In vivo prime editing rescues alternating hemiplegia of childhood in mice.

Cell

August 2025

Merkin Institute of Transformative Technologies in Healthcare, The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA; Howard Hughes Medical Institute, Harvard Univ

Alternating hemiplegia of childhood (AHC) is a neurodevelopmental disorder with no disease-modifying treatment. Mutations in ATP1A3, encoding an Na/K ATPase subunit, cause 70% of AHC cases. Here, we present prime editing (PE) and base editing (BE) strategies to correct ATP1A3 and Atp1a3 mutations in human cells and in two AHC mouse models.

View Article and Find Full Text PDF

The Na,K-ATPase is a heterodimeric ion pump consisting of various combinations of a catalytic α-subunit (α1, α2, α3, or α4, encoded by ) and a β-subunit (β1, β2, or β3, encoded by ). We have previously shown that knock-out (ko) mice exhibit rapid photoreceptor cell degeneration, whereas knock-in (ki) mice, which express the β1-subunit instead of the β2-subunit under regulatory elements of the gene, exhibit slowly progressive retinal dystrophy. Here, we performed a detailed analysis of the retinal phenotype of the ki mouse.

View Article and Find Full Text PDF